Haemonetics Corp (HAE)
85.55
+0.12
(+0.14%)
USD |
NYSE |
Nov 22, 16:00
83.01
-2.54
(-2.97%)
Pre-Market: 20:00
Haemonetics Cash from Financing (Quarterly): -74.80M for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -74.80M |
| June 30, 2024 | 333.69M |
| March 31, 2024 | -63.50M |
| December 31, 2023 | 109.43M |
| September 30, 2023 | -7.172M |
| June 30, 2023 | -0.598M |
| March 31, 2023 | -1.603M |
| December 31, 2022 | -49.68M |
| September 30, 2022 | -25.69M |
| June 30, 2022 | -23.40M |
| March 31, 2022 | -8.765M |
| December 31, 2021 | -2.035M |
| September 30, 2021 | -3.315M |
| June 30, 2021 | -1.634M |
| March 31, 2021 | 432.76M |
| December 31, 2020 | -149.94M |
| September 30, 2020 | -64.32M |
| June 30, 2020 | 148.95M |
| March 31, 2020 | 11.37M |
| December 31, 2019 | -46.15M |
| September 30, 2019 | -112.52M |
| June 30, 2019 | 16.09M |
| March 31, 2019 | 6.995M |
| December 31, 2018 | -76.21M |
| September 30, 2018 | -0.079M |
| Date | Value |
|---|---|
| June 30, 2018 | 18.66M |
| March 31, 2018 | -112.65M |
| December 31, 2017 | 8.306M |
| September 30, 2017 | -12.75M |
| June 30, 2017 | -3.549M |
| March 31, 2017 | -10.45M |
| December 31, 2016 | -45.39M |
| September 30, 2016 | 0.411M |
| June 30, 2016 | -4.986M |
| March 31, 2016 | -15.65M |
| December 31, 2015 | -2.99M |
| September 30, 2015 | -14.21M |
| June 30, 2015 | -29.77M |
| March 31, 2015 | 2.518M |
| December 31, 2014 | -0.222M |
| September 30, 2014 | -6.645M |
| June 30, 2014 | -28.81M |
| March 31, 2014 | -6.031M |
| December 31, 2013 | -10.80M |
| September 30, 2013 | -13.37M |
| June 30, 2013 | 9.504M |
| March 31, 2013 | -29.18M |
| December 31, 2012 | -3.774M |
| September 30, 2012 | 478.58M |
| June 30, 2012 | 16.23M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-149.94M
Minimum
Dec 2020
432.76M
Maximum
Mar 2021
25.68M
Average
-5.244M
Median
Cash from Financing (Quarterly) Benchmarks
| Boston Scientific Corp | 7.00M |
| Globus Medical Inc | 19.58M |
| ResMed Inc | -150.76M |
| Baxter International Inc | -146.00M |
| Integra Lifesciences Holdings Corp | -19.92M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 48.82M |
| Cash from Investing (Quarterly) | -23.37M |
| Free Cash Flow | 20.35M |
| Free Cash Flow Per Share (Quarterly) | 0.7687 |
| Free Cash Flow to Equity (Quarterly) | 38.02M |
| Free Cash Flow to Firm (Quarterly) | 44.68M |
| Free Cash Flow Yield | 0.46% |